For nearly 50 years, we’ve been deeply committed to enhancing the lives of patients everywhere. Whether it’s changing the outlook for one of the most aggressive types of breast cancer, pioneering treatments for a debilitating form of multiple sclerosis, or providing life-changing therapies for those facing vision loss, our mission remains steadfast. Today, as a member of the Roche Group, we remain dedicated to pursuing breakthrough research, developing life-changing medicines, unlocking advances in data and technology, and partnering across society to take on systemic issues that stand in the way of better healthcare for all. To accelerate R&D and further enhance therapeutic outcomes, we’re leveraging cutting-edge artificial intelligence capabilities.